Reviewed,
UniProtKB/Swiss-Prot P19540 (FA9_CANFA)
Last modified
June 16, 2009.
Version 98.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Coagulation factor IX EC=3.4.21.22 Alternative name(s): Christmas factor Cleaved into the following 2 chains: 1- Recommended name: Coagulation factor IXa light chain 2- Recommended name: Coagulation factor IXa heavy chain | ||
| Gene names |
| ||
| Organism | Canis familiaris (Dog) | ||
| Taxonomic identifier | 9615 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Laurasiatheria › Carnivora › Caniformia › Canidae › Canis |
Protein attributes
| Sequence length | 452 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca2+ ions, phospholipids, and factor VIIIa. |
| Catalytic activity | Selective cleavage of Arg-|-Ile bond in factor X to form factor Xa. |
| Subunit structure | Heterodimer of a light chain and a heavy chain; disulfide-linked. |
| Subcellular location | |
| Tissue specificity | Synthesized primarily in the liver and secreted in plasma. |
| Domain | Calcium binds to the gamma-carboxyglutamic acid (Gla) residues and, with stronger affinity, to another site, beyond the Gla domain. |
| Post-translational modification | Activated by factor XIa, which excises the activation peptide. The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains By similarity. |
| Involvement in disease | Defects in F9 are the cause of hemophilia B (HEMB). Ref.3 |
| Sequence similarities | Belongs to the peptidase S1 family. Contains 2 EGF-like domains. Contains 1 Gla (gamma-carboxy-glutamate) domain. Contains 1 peptidase S1 domain. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Blood coagulation |
| Cellular component | Secreted |
| Disease | Disease mutation Hemophilia |
| Domain | EGF-like domain Repeat Signal |
| Ligand | Calcium |
| Molecular function | Hydrolase Protease Serine protease |
| PTM | Cleavage on pair of basic residues Disulfide bond Gamma-carboxyglutamic acid Glycoprotein Hydroxylation Zymogen |
| Gene Ontology (GO) | |
| Biological process | blood coagulation Inferred from electronic annotation. Source: UniProtKB-KW proteolysisInferred from electronic annotation. Source: InterPro |
| Cellular component | extracellular region Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | calcium ion binding Inferred from electronic annotation. Source: UniProtKB-KW serine-type endopeptidase activityInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | By similarity | ||||||||
| Propeptide | 22 – 39 | 18 | PRO_0000027745 | ||||||||
| Chain | 40 – 452 | 413 | Coagulation factor IX | PRO_0000027746 | |||||||
| Chain | 40 – 183 | 144 | Coagulation factor IXa light chain | PRO_0000027747 | |||||||
| Propeptide | 184 – 217 | 34 | Activation peptide | PRO_0000027748 | |||||||
| Chain | 218 – 452 | 235 | Coagulation factor IXa heavy chain | PRO_0000027749 | |||||||
Regions | |||||||||||
| Domain | 40 – 85 | 46 | Gla | ||||||||
| Domain | 86 – 122 | 37 | EGF-like 1; calcium-binding Potential | ||||||||
| Domain | 123 – 164 | 42 | EGF-like 2 | ||||||||
| Domain | 218 – 450 | 233 | Peptidase S1 | ||||||||
Sites | |||||||||||
| Active site | 258 | 1 | Charge relay system | ||||||||
| Active site | 306 | 1 | Charge relay system | ||||||||
| Active site | 402 | 1 | Charge relay system | ||||||||
| Site | 183 – 184 | 2 | Cleavage; by factor XIa By similarity | ||||||||
| Site | 217 – 218 | 2 | Cleavage; by factor XIa By similarity | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 46 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 47 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 54 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 56 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 59 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 60 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 65 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 66 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 69 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 72 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 75 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 79 | 1 | 4-carboxyglutamate By similarity | ||||||||
| Modified residue | 103 | 1 | (3R)-3-hydroxyaspartate By similarity | ||||||||
| Glycosylation | 197 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 207 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 297 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 57 ↔ 62 | By similarity | |||||||||
| Disulfide bond | 90 ↔ 101 | By similarity | |||||||||
| Disulfide bond | 95 ↔ 110 | By similarity | |||||||||
| Disulfide bond | 112 ↔ 121 | By similarity | |||||||||
| Disulfide bond | 127 ↔ 138 | By similarity | |||||||||
| Disulfide bond | 134 ↔ 148 | By similarity | |||||||||
| Disulfide bond | 150 ↔ 163 | By similarity | |||||||||
| Disulfide bond | 171 ↔ 326 | By similarity | |||||||||
| Disulfide bond | 243 ↔ 259 | By similarity | |||||||||
| Disulfide bond | 373 ↔ 387 | By similarity | |||||||||
| Disulfide bond | 398 ↔ 426 | By similarity | |||||||||
Natural variations | |||||||||||
| Natural variant | 418 | 1 | G → E in HEMB. Ref.3 | ||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs." Axelrod J.H., Read M.S., Brinkhous K.M., Verma I.M. Proc. Natl. Acad. Sci. U.S.A. 87:5173-5177(1990) [PubMed: 2367529] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [2] | "Molecular cloning of a cDNA encoding canine factor IX." Evans J.P., Watzke H.H., Ware J.L., Stafford D.W., High K.A. Blood 74:207-212(1989) [PubMed: 2752110] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [3] | "Canine hemophilia B resulting from a point mutation with unusual consequences." Evans J.P., Brinkhous K.M., Brayer G.D., Reisner H.M., High K.A. Proc. Natl. Acad. Sci. U.S.A. 86:10095-10099(1989) [PubMed: 2481310] [Abstract] Cited for: VARIANT HEMB GLU-418. |
Cross-references
Sequence databases | |
|---|---|
| M21757 mRNA. Translation: AAA75006.1. M33826 mRNA. Translation: AAA30844.1. | |
| PIR | A30351. |
| RefSeq | NP_001003323.1. |
| UniGene | Cfa.3857 |
3D structure databases | |
| HSSP | HSSP built from PDB template 1CFH based on UniProtKB P00740. |
| SMR | P19540. Positions 40-185, 218-452. |
| ModBase | Search... |
Protein family/group databases | |
| MEROPS | S01.214. |
Genome annotation databases | |
| Ensembl | ENSCAFG00000018998. Canis familiaris. [Contig view] |
| GeneID | 404015. |
| KEGG | cfa:404015. |
Phylogenomic databases | |
| HOVERGEN | P19540. |
Enzyme and pathway databases | |
| BRENDA | 3.4.21.22. 463. |
Family and domain databases | |
| InterPro | IPR002383. Coagulation_factor_Gla. IPR006209. EGF. IPR006210. EGF-like. IPR013032. EGF-like_reg_CS. IPR000152. EGF-type_Asp/Asn_hydroxyl_CS. IPR000742. EGF_3. IPR001881. EGF_Ca_bd. IPR018097. EGF_Ca_bd_CS. IPR000294. GLA_domain. IPR012224. Pept_S1A_FX. IPR018114. Peptidase_S1/S6_AS. IPR001254. Peptidase_S1_S6. IPR001314. Peptidase_S1A. [Graphical view] |
| Pfam | PF00008. EGF. 2 hits. PF00594. Gla. 1 hit. PF00089. Trypsin. 1 hit. [Graphical view] |
| PIRSF | PIRSF001143. Factor_X. 1 hit. |
| PRINTS | PR00722. CHYMOTRYPSIN. PR00001. GLABLOOD. |
| SMART | SM00181. EGF. 1 hit. SM00179. EGF_CA. 1 hit. SM00069. GLA. 1 hit. SM00020. Tryp_SPc. 1 hit. [Graphical view] |
| PROSITE | PS00010. ASX_HYDROXYL. 1 hit. PS00022. EGF_1. 1 hit. PS01186. EGF_2. 2 hits. PS50026. EGF_3. 1 hit. PS01187. EGF_CA. 1 hit. PS00011. GLA_1. 1 hit. PS50998. GLA_2. 1 hit. PS50240. TRYPSIN_DOM. 1 hit. PS00134. TRYPSIN_HIS. 1 hit. PS00135. TRYPSIN_SER. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Entry information
| Entry name | FA9_CANFA | ||||||||
| Accession | Primary (citable) accession number: P19540 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| SIMILARITY comments Index of protein domains and families |

Clusters with


